跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,412 条关于
“Sara Kenkare-Mitra”
全部
4,412
临床试验
3,689
药物
407
机构
79
资讯
237
5个月前
Rani Therapeutics Strengthens Leadership Team with Key Strategic Appointments to Advance Oral Biologics Platform
11个月前
Alector's Latozinemab Fails Phase III Trial for Frontotemporal Dementia, Company Cuts Workforce by Half
2个月前
ICMR Licenses Three Indigenous Biomedical Technologies to Emcure and Biological E for Cancer and Infectious Disease Control
2年前
Biophytis Advances Ruvembri to Phase 3 Trial for Sarcopenia Treatment Following Promising Phase 2 Results
去年
Biohaven's Troriluzole Shows Promise in Slowing Spinocerebellar Ataxia Progression
3年前
Biophytis Receives Regulatory Approval to Launch First-Ever Phase 3 Trial for Sarcopenia Treatment
3年前
Biophytis Receives FDA Authorization for First-Ever Phase 3 Sarcopenia Trial
去年
L-Arginine Shows Promise but Falls Short of Statistical Significance in Spinocerebellar Ataxia Type 6 Trial
去年
EMA Recommends Approval of Aqneursa for Niemann-Pick Type C Disease Treatment
去年
Biophytis Presents BIO101 Obesity Program Data at SCWD International Congress, Plans Phase 2 Trial
第 1 页,共 24 页
上一页
下一页